The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis

Journal of Immunology

Volumn 169, Issue 3, 2002, Pages 1459-1466

  Kagari, Takashi ^a   Doi, Hiromi ^a   Shimozato, Takaichi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COLLAGEN ANTIBODY; CYTOKINE; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCID MOUSE; T LYMPHOCYTE;

EID: 0036681846     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.3.1459     Document Type: Article

References (42)

1. Immunisation against heterologous type II collagen induces arthritis in mice
2. Type II collagen autoimmunity in animals and provocations leading to arthritis
3. Induction of arthritis with monoclonal antibodies to collagen
4. Collagen-induced arthritis in mice: Synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monolonal antibodies to type II collagen
5. Cytokine pathways and joint inflammation in rheumatoid arthritis
6. Macrophage inflammatory protein-1α: A novel chemotactic cytokine for macrophages in rheumatoid arthritis
7. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis
8. Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression
9. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA)
10. Elevated levels of TNF in the joints of adjuvant arthritic rats
11. Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls
12. Biologic basis for interleukin-1 in disease
13. An interleukin 1 like factor stimulates bone resorption in vitro
14. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production
15. 3H]tetracycline excretion from prelabeled mice
16. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level
17. In vivo effects of recombinant human interleukin-6 in primates: Stimulated production of platelets
18. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells
19. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
20. Rheumotoid arthritis
21. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen induced arthritis
22. Association of rheumatoid arthritis with a functional chemokine receptor. CCR5
23. + T cells in response to MIP-1α and MIP-1β
24. The intracellular signaling pathways involved in MCP-I-stimulated T cell migration across microvascular endothelium
25. Human chondroytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines
26. The role of chemokines in inflammatory joint disease
27. The role of monoyte chemoattractant protein-1 (MCP-I) in the pathogenesis of collagen-induced arthritis in rats
28. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type 1 receptor-deficient mice
29. Impaired immune and acute-phase responses in interleukin-6-deficient mice
30. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
31. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease
32. Fixation, embedding, and sectioning
33. IL-1 αβ blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blokade only ameliorates joint inflammation
34. Blockage of inteleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis
35. Delayed onset and reduced severity of collagen-induced arthritis in inteleukin-6-deficient mice
36. Interleukin 6 is required for the development of collagen-induced arthritis
37. Interleukin-6 reduces cartilage destruction during experimental arthritis: A study in interleukin-6-deficient mice
38. IL-6 stimulates osteoclas-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release
39. B cell-deficient mice do not develop type II collagen induced arthritis (CIA)
40. Synergy between anti-CD4 Md anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis
41. Collagen-induced arthritis developnmnt requires αβ T cells but not γδ T cells: Studies with T cell-deficient (TCR mutant) mice
42. Isolation of T cell line capable of protecting mice against collagen-induced arthritis